Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT)

被引:2
|
作者
Miron-Rubio, Manuel [1 ,2 ]
Parra Jordan, Juan Jose [3 ]
Gonzalez Ramallo, Victor Jose [4 ]
Mujal Martinez, Abel [5 ]
Fernandez Muixi, Josefina [6 ]
Iglesias Gallego, Marina [7 ]
Lucas Nunez, Maria Cruz [8 ]
Rodado Alabau, Elisa [9 ]
Perez-Campoamor, Sandra Vidal [10 ]
Uria, Estefany [11 ]
机构
[1] Hosp Univ Torrejon, Unidad Hospitalizac, Torrejon De Ardoz, Madrid, Spain
[2] Univ Francisco Vitoria, Fac Med, Madrid, Spain
[3] Hosp Univ Marques Valdecilla, Unidad Hospitalizac & Domicilio, Santander, Santander, Spain
[4] Hosp Gen Univ Gregorio Maranon, Unidad Hospitalizac & Domicilio, Madrid, Madrid, Spain
[5] Hosp Univ Parc Tauli, Unidad Hospitalizac & Domicilio, Sabadell, Barcelona, Spain
[6] Pius Hosp Valls, Unidad Hospitalizac & Domicilio, Serv Med Interna, Valls, Tarragona, Spain
[7] Hosp Barbanza, Unidad Hospitalizac & Domicilio, Ribeira, A Coruna, Spain
[8] Hosp Univ Burgos, Unidad Hospitalizac & Domicilio, Burgos, Burgos, Spain
[9] Verge Cinta, Unidad Hospitalizac Domicilio, Tortosa, Tarragona, Spain
[10] Merck Sharp & Dohme Ltd, Madrid, Spain
[11] Pharmalex Spain, Market Access Area, Barcelona, Spain
关键词
Hospital at home; outpatient parenteral antimicrobial therapy (OPAT); cost analysis; skin and skin structure infections (SSSIs); SOFT-TISSUE INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL THERAPY; COMPLICATED SKIN; MANAGEMENT; EXPERIENCE; ADULTS; UK; EPIDEMIOLOGY; ORITAVANCIN;
D O I
10.37201/req/134.2022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective. To describe and quantify resource use and direct health costs associated with skin and skin structure infections (SSSIs) caused by Gram-positive bacteria in adults receiving outpatient parenteral antimicrobial therapy (OPAT), administered by Hospital at Home units (HaH) in Spain. Material and methods. Observational, multicenter, retrospective study. We included patients of both sexes included in the HaH-based OPAT Registry during 2011 to 2017 who were hospitalized due to SSSIs caused by Gram-positive bacteria. Resource use included home visits (nurses and physician), emergency room visits, conventional hospitalization stay, HaH stay and antibiotic treatment. Costs were quantified by multiplying the natural units of the resources by the corresponding unit cost. All costs were updated to 2019 euros. Results. We included 194 episodes in 189 patients from 24 Spanish hospitals. The most frequent main diagnoses were cellulitis (26.8%) and surgical wound infection (24.2%), and 94% of episodes resulted in clinical improvement or cure after treatment. The median HaH stay was 13 days (interquartile range [IR]:8-22.7), and the conventional hospitalization stay was 5 days (IR: 1-10.7). The mean total cost attributable to the complete infectious process was _7,326 (95% confidence interval: _6,316-_8,416). Conclusions. Our results suggest that OPAT administered by HaH is a safe and efficient alternative for the management of these infections and could lead to lower costs compared with hospital admission.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 16 条
  • [1] Telavancin Activity against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections
    Pfaller, M. A.
    Rhomberg, P. R.
    Sader, H. S.
    Mendes, R. E.
    Jones, R. N.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (05) : 304 - 311
  • [2] Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin
    Nathwani, Dilip
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (03) : 447 - 453
  • [3] Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections
    Seaton, R. A.
    Sharp, E.
    Bezlyak, V.
    Weir, C. J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (03) : 243 - 248
  • [4] Telavancin: A Lipoglycopeptide Antimicrobial for the Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria in Adults
    Chang, Mei H.
    Kish, Troy D.
    Fung, Horatio B.
    CLINICAL THERAPEUTICS, 2010, 32 (13) : 2160 - 2185
  • [5] Implementing a Toolkit to Improve the Education of Patients on Home-Based Outpatient Parenteral Antimicrobial Therapy (OPAT)
    Keller, Sara C.
    Salinas, Alejandra
    Gurses, Ayse P.
    Levering, Mayo
    Hohl, Dawn
    Hirsch, David
    Grimes, Michael
    Ziemba, Kaylin
    Cosgrove, Sara E.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2022, 48 (09) : 468 - 474
  • [6] Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria
    Stevens, Dennis L.
    JOURNAL OF INFECTION, 2009, 59 : S32 - S39
  • [7] In Vitro Activity of Tedizolid Against Gram-Positive Bacteria in Patients With Skin and Skin Structure Infections and Hospital-Acquired Pneumonia: A Korean Multicenter Study
    Lee, Yangsoon
    Hong, Sung Kuk
    Choi, SungHak
    Weonbinlm
    Yong, Dongeun
    Lee, Kyungwon
    ANNALS OF LABORATORY MEDICINE, 2015, 35 (05) : 523 - 530
  • [8] Institutional Perspective on the Impact of Positive Blood Cultures on the Economic and Clinical Outcomes of Patients With Complicated Skin and Skin Structure Infections: Focus on Gram-Positive Infections
    Micek, Scott T.
    Hoban, Alex P.
    Pham, Victor
    Doherty, Joshua A.
    Kollef, Mann H.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1759 - 1768
  • [9] Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies
    Corey, G. Ralph
    Loutit, Jeffery
    Moeck, Greg
    Wikler, Matthew
    Dudley, Michael N.
    O'Riordan, William
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [10] Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service
    Mackintosh, C. L.
    White, H. A.
    Seaton, R. A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (02) : 408 - 415